Literature DB >> 21293260

Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.

Ondřej Hes1, Tomáš Vaněček, Fredrik Petersson, Petr Grossmann, Milan Hora, Delia M Perez Montiel, Petr Steiner, Miroslav Dvořák, Michal Michal.   

Abstract

BACKGROUND: Recently a somatic point mutation in the FOXL2 gene has been characterized in ovarian adult type of granulosa cell tumor (ATGCT) (94.6%), thecomas (12.5%), but not in juvenile type of ovarian granulosa cell tumor, other ovarian sex cord tumors and ovarian surface epithelial neoplasms. Whether this mutation is present in testicular ATGCT or incompletely differentiated sex cord stromal tumor (ISCST) is not known.
DESIGN: Four ATGCTs, 4 ISCST were immunohistochemically investigated with anti-FOXL2 and 3 ovarian ATGCTs were used as positive control.
RESULTS: Weak-to-moderate immunoreactivity was found in all tested testicular and ovarian tumors. PCR and direct sequencing were used for detection of c.402C>G of the FOXL2 gene. No mutation was found in any of the testicular ATGCTs or ISCSTs whereas all ovarian tumors showed the c.402C>G point mutation of the FOXL2 gene.
CONCLUSIONS: On the basis of this small series of these rare testicular neoplasms, it seems that the c.402C>G mutation of the FOXL2 gene frequently found in adult type of ovarian GCT does not play any significant role in the development of ATGCT and ISCST.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293260     DOI: 10.1097/PAI.0b013e3182039ef2

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

Review 1.  The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Authors:  Anthony N Karnezis; Kathleen R Cho; C Blake Gilks; Celeste Leigh Pearce; David G Huntsman
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

2.  [Testicular tumors].

Authors:  Felix Bremmer
Journal:  Pathologie (Heidelb)       Date:  2022-10-20

3.  FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells.

Authors:  Xing-Long Liu; Yu-Han Meng; Jian-Li Wang; Biao-Bing Yang; Fan Zhang; Sheng-Jian Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.

Authors:  Melissa K McConechy; Anniina Färkkilä; Hugo M Horlings; Aline Talhouk; Leila Unkila-Kallio; Hannah S van Meurs; Winnie Yang; Nirit Rozenberg; Noora Andersson; Katharina Zaby; Saara Bryk; Ralf Bützow; Johannes B G Halfwerk; Gerrit K J Hooijer; Marc J van de Vijver; Marrije R Buist; Gemma G Kenter; Sara Y Brucker; Bernhard Krämer; Annette Staebler; Maaike C G Bleeker; Markku Heikinheimo; Stefan Kommoss; C Blake Gilks; Mikko Anttonen; David G Huntsman
Journal:  J Natl Cancer Inst       Date:  2016-06-13       Impact factor: 13.506

5.  The transcriptional targets of mutant FOXL2 in granulosa cell tumours.

Authors:  Roseanne Rosario; Hiromitsu Araki; Cristin G Print; Andrew N Shelling
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

Review 6.  Early Gonadal Development and Sex Determination in Mammal.

Authors:  Yanshe Xie; Changhua Wu; Zicong Li; Zhenfang Wu; Linjun Hong
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

Review 7.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.